The global tissue banking market is majorly driven by an increasing number of biobanking technology that has improved in the areas of science such as biospecimen and biorepository. The usage of robotic sample handling and software designed for storage management makes the biobanking process more effective. With the rising in the harmonization of biobanks and research collaboration, the tissue banking industry is anticipated to grow at a significant rate during the forecast period. Newly established biobanks collaborate with each other to enhance the existing tissue banking potentials. Biobanks are the place that stores human biological samples for future use. It is called as biorepositories, bioresources, and tissue banks.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/tissu-banking-market-size
One of the largest cord blood & tissue bank of Australia in 2018 completed the acquisition of the largest private cord blood & tissue bank of Canada, Inspection Lifebank. The combined entity creates one of the top 10 companies of the globe in the tissue banking industry. Together, these banks store more than 100,000 client samples and establish an excellent platform for further international expansion. With this collaboration, the two companies are provided with a stronger base from which to expand current clinical trials and R&D activities across the globe. The merger between these two tissue banks creates an ample opportunity to bring together cord blood innovators and research potential new therapy opportunities; thereby, they tend to drive the global tissue banking market in the near future.
Browse for Full Report [email protected] https://www.omrglobal.com/industry-reports/tissue-banking-market-size
LifeLink Tissue Bank is a division of LifeLink Foundation, Inc. based in Tampa, Florida. The tissue bank in September 2017, has established a new distribution partnership HCT Regenerative, in which allografts for patients suffering from sports, orthopedic and/or spine injuries will be provided by LifeLink Tissue Bank. HCT Regenerative is a Taiwan-based company, incorporated in July 2016. It is the first company in Taiwan focusing on processing human tissue for producing regenerative biomaterials for clinical use. LifeLink will procure and provide some bone and tissues to HCT for use in its operations. Such collaboration in the tissue banking industry is expected to catalyze the market in the near future.
Global Tissue Banking Market- Segmentation
- Consumables & Media
- Medical Research & Drug Development
Global Tissue Banking Market– Segment by Region
- Rest of Europe
- Rest of Asia-Pacific
Rest of the World
- Latin America
- Middle East and Africa
- AMS Biotechnology Ltd.
- AstaZeneca PLC
- Beckman Coulter Inc.
- BioCision LLC.
- BioStorage Technologies, Inc.
- Custom Biogenic Systems, Inc.
- Eppendrof AG
- Genzyme Corp. (A Sanofi Company)
- GlaxoSmithKline PLC
- Merck KGaA
- Organ Recovery Systems, Inc.
- Pfizer Inc.
- Regeneron Pharmaceuticals, Inc.
- Stryker Corp.
- Taylor Wharton
- Tecan Group
- Teva Pharmaceuticals Industries Ltd.
- Thermo Fisher Scientific Inc.
- Zimmer Biomet Holdings, Inc.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/tissue-banking-market-size
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404